Glucose deprivation and identification of TXNIP as an immunometabolic modulator of T cell activation in cancer
TXNIP is at the interface between immunometabolism and T cell activation and could represent a potential target for immuno-oncology treatments.
Authors
- Dawid Walas (ORCID: https://orcid.org/0000-0003-0354-2510)
- Adrien Zichi
- Étienne Becht (ORCID: https://orcid.org/0000-0003-1859-9202)
- Nicolas Provost
- Agathe Dubuisson (ORCID: https://orcid.org/0000-0002-7526-0769)
- Fabien Melchiore
- Samantha Knockaert
- Hélène Darville
- Adèle Mangelinck (ORCID: https://orcid.org/0009-0008-7454-8198)
- Véronique Blanc
- Sandra Dromaint-Catesson
- Manon Fasquel
- Vincent Lombardi (ORCID: https://orcid.org/0000-0002-5748-9383)
- Céline Lefèbvre
- Jean‐Pierre Galizzi
- Wendy Philippon
Institutions
- University of Opole (PL)
- Servier (France) (FR)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.3389/fimmu.2025.1548509
- Citations
- 2
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 1.59
Funders
- Servier